EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue

Yahui Zhang, Yi Lin, Guoqiang Li, Yuan Yuan, Xuejiao Wang, Na Li, Chuanhao Xiong, Yueying Yang, Yuhang Ma, Zhijian Zhang, Xiaoying Ding

Biology of Reproduction · 09.06.2023 · 108 (6) · 945-959

DOI: 10.1093/biolre/ioad032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, online erschienen am 17.03.2023. Verfasst von Yahui Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Hyperandrogenism, Hyperinsulinism. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Cross-Institute Research Fund of Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome is a complicated hormonal and metabolic disorder. The exact pathogenesis of polycystic ovary syndrome is not clear thus far. Inflammation is involved in the progression of polycystic ovary syndrome. In addition, brown adipose tissue activity is impaired in polycystic ovary syndrome. Interestingly, glucagon-like peptide-1 receptor agonists have been reported to alleviate inflammation and promote browning of white adipose tissue. In this study, the effects of glucagon-like peptide-1 receptor agonists on polycystic ovary syndrome mice were explored. Mice were randomly assigned into four groups: control, dehydroepiandrosterone, dehydroepiandrosterone + liraglutide, and dehydroepiandrosterone + semaglutide. Relative indexes were measured after glucagon-like peptide-1 receptor agonist intervention. Glucose metabolism in polycystic ovary syndrome mice was ameliorated by glucagon-like peptide-1 receptor agonists, while the reproductive endocrine disorder of polycystic ovary syndrome mice was partially reversed. The messenger ribonucleic acid levels of steroidogenic enzymes and the expression of inflammatory mediators in serum and ovaries of polycystic ovary syndrome mice were improved. Furthermore, toll-like receptor 4 and phosphorylation of nuclear factor-kappa B protein levels were decreased by glucagon-like peptide-1 receptor agonists in ovary. Notably, after glucagon-like peptide-1 receptor agonist intervention, the expression of brown adipose tissue marker levels was considerably raised in the white adipose tissue of polycystic ovary syndrome mice. In conclusion, the hyperinsulinemia and hyperandrogenemia of polycystic ovary syndrome mice were alleviated by glucagon-like peptide-1 receptor agonist intervention, which was associated with mitigating inflammation and stimulating adipose tissue browning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceHyperandrogenismHyperinsulinismFemaleHumansMiceAnimalsGlucagon-Like Peptide-1 ReceptorInflammationAdipose Tissue, WhiteDehydroepiandrosterone

Stichwörter der Autor:innen

GLP-1 receptor agonists (GLP-1RAs)browninghyperandrogenemiahyperinsulinemiainflammationpolycystic ovary syndrome (PCOS)

Substanzen

Glucagon-Like Peptide-1 ReceptorDehydroepiandrosterone

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Cross-Institute Research Fund of Shanghai Jiao Tong University

Zitieren

APA

Zhang, Y., Lin, Y., Li, G., Yuan, Y., Wang, X., Li, N., Xiong, C., Yang, Y., Ma, Y., Zhang, Z., & Ding, X. (2023). Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue. Biology of Reproduction, 108(6), 945-959. https://doi.org/10.1093/biolre/ioad032

Vancouver

Zhang Y, Lin Y, Li G, Yuan Y, Wang X, Li N, et al. Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue. Biology of Reproduction. 2023;108(6):945-959. doi:10.1093/biolre/ioad032

BibTeX
@article{Zhang2023,
  author = {Zhang, Yahui and Lin, Yi and Li, Guoqiang and Yuan, Yuan and Wang, Xuejiao and Li, Na and Xiong, Chuanhao and Yang, Yueying and Ma, Yuhang and Zhang, Zhijian and Ding, Xiaoying},
  title = {Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue},
  journal = {Biology of Reproduction},
  year = {2023},
  volume = {108},
  number = {6},
  pages = {945--959},
  doi = {10.1093/biolre/ioad032}
}
Kostenlos starten →